186-Tsuboi-TumorDyn
Author reviewed
Images of tumor-bearing mice or KPL-4 cells apoptosis treated with Kadcyla for different time.
Project ID
186-Tsuboi-TumorDyn
Title
Images of tumor-bearing mice or KPL-4 cells apoptosis treated with Kadcyla for different time.
Method Summary
See details in Tsuboi S, et. al. (2020) RSC Adv., 10(63):38244-38250.
Image datasets
zipped 29 files / 82.5 MB, raw image 29 files / 86.4 MB, total 58 files / 168.9 MB
Quantitative datasets
zipped 0 files / 0 bytes, raw bdml 0 files / 0 bytes, total 0 files / 0 bytes
Medical Subject Headings
-
Method involved in biological imaging
People
Contact
Takashi Jin
RIKEN
Center for Biosystems Dynamics Research
Laboratory for Developmental Dynamics
Imaging dataset contributor
-
Quantitative dataset contributor
-
Datasets
Thumbnail
Dataset
Organism
Kind / Links
NIR fluorescence images of a breast-tumour bearing mouse injected with ICG labelled Kadcyla for 0 day.
NIR fluorescence images of a breast-tumour bearing mouse injected with ICG labelled Kadcyla for 1 day.
NIR fluorescence images of a breast-tumour bearing mouse injected with ICG labelled Kadcyla for 3 days.
NIR fluorescence images of a breast-tumour bearing mouse injected with ICG labelled Kadcyla for 5 days.
NIR fluorescence image of breast tumour-bearing mice injected with ICG-EGFP for 0 day.
NIR fluorescence image of breast tumour-bearing mice injected with ICG-EGFP for 3 days.
NIR fluorescence image of breast tumour-bearing mice injected with ICG-mPlum for 0 day.
NIR fluorescence image of breast tumour-bearing mice injected with ICG-mPlum for 3 days.
Images of HER2-positive breast tumour cells (KPL-4) treated with 0.01 nM Kadcyla for 24h for flow cytometric analysis.
Images of HER2-positive breast tumour cells (KPL-4) treated with 0.1 nM Kadcyla for 24h for flow cytometric analysis.
Images of HER2-positive breast tumour cells (KPL-4) treated without Kadcyla for 24h for flow cytometric analysis.
Images of HER2-positive breast tumour cells (KPL-4) treated with 100 nM Kadcyla for 24h for flow cytometric analysis.
Images of HER2-positive breast tumour cells (KPL-4) treated with 10 nM Kadcyla for 24h for flow cytometric analysis.
Images of HER2-positive breast tumour cells (KPL-4) treated with 1 nM Kadcyla for 24h for flow cytometric analysis.
Images of HER2-positive breast tumour cells (KPL-4) treated with 0.01 nM Kadcyla for 48h for flow cytometric analysis.
Images of HER2-positive breast tumour cells (KPL-4) treated with 0.1 nM Kadcyla for 48h for flow cytometric analysis.
Images of HER2-positive breast tumour cells (KPL-4) treated without Kadcyla for 48h for flow cytometric analysis.
Images of HER2-positive breast tumour cells (KPL-4) treated with 100 nM Kadcyla for 48h for flow cytometric analysis.
Images of HER2-positive breast tumour cells (KPL-4) treated with 10 nM Kadcyla for 48h for flow cytometric analysis.
Images of HER2-positive breast tumour cells (KPL-4) treated with 1 nM Kadcyla for 48h for flow cytometric analysis.
Images of HER2-positive breast tumour cells (KPL-4) treated with 0.01 nM Kadcyla for 72h for flow cytometric analysis.
Images of HER2-positive breast tumour cells (KPL-4) treated with 0.1 nM Kadcyla for 72h for flow cytometric analysis.
Images of HER2-positive breast tumour cells (KPL-4) treated without Kadcyla for 72h for flow cytometric analysis.
Images of HER2-positive breast tumour cells (KPL-4) treated with 100 nM Kadcyla for 72h for flow cytometric analysis.
Images of HER2-positive breast tumour cells (KPL-4) treated with 10 nM Kadcyla for 72h for flow cytometric analysis.
Images of HER2-positive breast tumour cells (KPL-4) treated with 1 nM Kadcyla for 72h for flow cytometric analysis.
NIR fluorescence images of breast tumour-bearing mice treated with 0.2mg Kadcyla injected with ICG- EGFP-Annexin for 0 day.
NIR fluorescence images of breast tumour-bearing mice treated with 0.2mg Kadcyla injected with ICG- EGFP-Annexin for 1 day.
NIR fluorescence images of breast tumour-bearing mice treated with 0.2mg Kadcyla injected with ICG- EGFP-Annexin for 2 days.